Patent application number | Description | Published |
20090018057 | OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES - Oil-in-water emulsion comprising a non-steroidal anti-inflammatory drug and a quaternary ammonium halide useful for the prevention and treatment of inflammation in the eye, and process for manufacturing thereof. | 01-15-2009 |
20090124565 | COMPOSITION COMPRISING AT LEAST ONE NUCLEOSIDIC MOIETY AS A THERAPEUTIC AGENT, AND CKC - Composition comprising at least one nucleosidic moiety and cetalkonium chloride and pharmaceutical use thereof for prevention, treatment or relief of eye, lung, and/or respiratory tract conditions. | 05-14-2009 |
20090169629 | MICELLAR COMPOSITIONS WITH OPHTHALMIC APPLICATIONS - This invention relates to micellar compositions comprising at least one pharmaceutically active substance and a mixture of n-alkyl dimethyl benzyl ammonium chlorides, wherein the mixture comprises more than 30% n-alkyl dimethyl benzyl ammonium chlorides having a chain length superior or equal to C | 07-02-2009 |
20090170944 | OPHTHALMIC MICELLAR COMPOSITIONS WITH ENHANCED STABILITY - This invention relates to micellar compositions comprising at least one pharmaceutically active substance and a mixture of n-alkyl dimethyl benzyl ammonium chlorides, wherein the mixture comprises more than 30% n-alkyl dimethyl benzyl ammonium chlorides having a chain length superior or equal to C16, wherein the pharmaceutically active substance exhibits an improved stability. In particular, a composition is provided that comprises cetalkonium chloride micelles incorporating the prostaglanding-like therapeutic agent, latanoprost. This invention also relates to ophthalmic compositions containing such micellar compositions and methods of using these ophthalmic compositions for the treatment of eye conditions. | 07-02-2009 |
20100286065 | TOPICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES AND CONDITIONS - The present invention relates to a new therapeutic approach for the treatment of eye diseases or conditions that allows for the delivery of corticosteroids to the eye's surface but does not cause any of the usual side effects associated with topical administration of corticosteroids. More specifically, the present invention provides methods of treatment involving the administration of a corticosteroid prodrug, such as dexamethasone palmitate, to the surface of the eye. Also provided are pharmaceutical compositions and kits for carrying out such methods of treatment. | 11-11-2010 |
20110021443 | OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES - Oil-in-water emulsion including a non-steroidal anti-inflammatory drug and a quaternary ammonium halide useful for the prevention and treatment of inflammation in the eye, and process for manufacturing thereof. | 01-27-2011 |
20110313038 | CATIONIC OIL-IN-WATER EMULSIONS CONTAINING PROSTAGLANDINS AND USES THEREOF - A colloidal cationic oil-in-water emulsion includes: —a prostaglandin, —an oil having a iodine value ≦2, —one or more surfactants including at least one quaternary ammonium compound, —water, wherein the prostaglandin/total sum of surfactants mass ratio is included between 0.5 and 5. The use of the cationic oil-in-water emulsions for enhancing the stability of the prostaglandins, for the treatment of ocular hypertension and/or glaucoma, for promoting growth of eyelashes and/or for treating eyelash hypotrichosis is also described. | 12-22-2011 |
20110319488 | ANIONIC OIL-IN-WATER EMULSIONS CONTAINING PROSTAGLANDINS AND USES THEREOF - A colloidal anionic oil-in-water emulsion includes a prostaglandin, an oil having a iodine value ≦2, a surfactant and water, provided the anionic oil-in-water emulsion does not contain polyvinyl alcohol. The use of the anionic oil-in-water emulsions for enhancing the stability of the prostaglandins, for the treatment of ocular hypertension and/or glaucoma, for promoting growth of eyelashes and/or for treating eyelash hypotrichosis is also described. | 12-29-2011 |
20120225939 | Use of Prostaglandins F2Alpha and Analogues for the Healing of Corneal and Conjunctival Lesions - The invention relates to a composition for use in treating corneal and conjunctival lesions, wherein the composition comprises a prostaglandin F2alpha or analogue, in a therapeutic amount, said composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative; the invention also relates to a method for treating surface ocular conditions in a patient in need thereof, comprising administering a composition of the invention. | 09-06-2012 |
20120238536 | Method for Treating Retinal Conditions Using an Intraocular Tamponade - Composition comprising at least one fatty acid glycerol ester for use during or after a vitrectomy procedure, said composition being bioresorbable, being injectable in the vitreous cavity, having a density below 1, more preferably comprised between 0.90 and 1, or a density above 1 more preferably between 1 and 1.5; having a surface tension of less than 50 dynes/cm more preferably ranging from 20 and 30 dynes/cm, being not susceptible to emulsify into droplets when injected; method for treating a retinal disorder involving the use of said composition. | 09-20-2012 |
20130164285 | Water-in-Oil Type Emulsion for Treating a Disease of the Eye - The invention relates to a composition for administering with a sustained release kinetic a therapeutically effective amount of a therapeutic agent to a subject in need thereof for treating diseases or conditions of the eye, wherein the composition is an water-in-oil type emulsion comprising an oil phase, a lipophilic surfactant dissolved in the oil phase, an aqueous phase dispersed in the oil phase, a hydrophilic therapeutic agent dissolved in the aqueous dispersed phase, and wherein the composition is intraocularly injectable, wherein the composition has a density lower than 1. The invention also relates to a pharmaceutical composition or to a medicament comprising the composition of the invention, and to a method for treating a condition or disease of the eye comprising administering a therapeutic amount of the composition of the invention. The invention also relates to a device comprising the composition of the invention. | 06-27-2013 |
20130337019 | COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS - Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions. | 12-19-2013 |
20150025020 | SELF-PRESERVED OIL DISPERSIONS COMPRISING BORIC ACID - The present invention relates to a self-preserved oil dispersion. Especially, the present invention relates to a self-preserved oil dispersion including a dispersed oil phase, an aqueous phase and at least one surfactant, wherein said oil dispersion comprises boric acid in an amount ranging from 0.005% to 0.075% in weight of the total weight of the oil dispersion, said amount of boric acid being a preservative effective amount so that the oil dispersion has a preservative activity. | 01-22-2015 |
20160082107 | COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS - Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions. | 03-24-2016 |
Patent application number | Description | Published |
20110021443 | OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES - Oil-in-water emulsion including a non-steroidal anti-inflammatory drug and a quaternary ammonium halide useful for the prevention and treatment of inflammation in the eye, and process for manufacturing thereof. | 01-27-2011 |
20110118349 | USE OF PROSTAGLANDINS F2ALPHA AND ANALOGUES FOR THE HEALING OF CORNEAL AND CONJUNCTIVAL LESIONS - A composition for use in treating corneal and conjunctival lesions, includes a prostaglandin F2alpha or analogue, in a therapeutic amount, the composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative. A method for treating surface ocular conditions in a patient in need thereof, includes administering an effective amount of the composition. | 05-19-2011 |
20110124616 | METHOD FOR TREATING RETINAL CONDITIONS USING AN INTRAOCULAR TAMPONADE - A composition includes at least one fatty acid glycerol ester for use during or after a vitrectomy procedure, the composition being bioresorbable, being injectable in the vitreous cavity, having a density below 1, more preferably between 0.90 and 1, or a density above 1, more preferably between 1 and 1.5; having a surface tension of less than 50 dynes/cm more preferably ranging from 20 and 30 dynes/cm, being not susceptible to emulsify into droplets when injected; method for treating a retinal disorder involving the use of the composition. | 05-26-2011 |
20110201689 | COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS - Composition containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, the composition including at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least carbon atoms. Ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions are also disclosed. | 08-18-2011 |
20120058187 | WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE - A composition is described herein for administering with a sustained release kinetic a therapeutically effective amount of a therapeutic agent to a subject in need thereof for treating diseases or conditions of the eye, wherein the composition is an water-in-oil type emulsion comprising an oil phase, a lipophilic surfactant dissolved in the oil phase, an aqueous phase dispersed in the oil phase, a hydrophilic therapeutic agent dissolved in the aqueous dispersed phase, and wherein the composition is intraocularly injectable, wherein the composition has a density lower than 1. Some embodiments also relate to a pharmaceutical composition or to a medicament comprising a composition described herein, and to a method for treating a condition or disease of the eye comprising administering a therapeutic amount of a composition described herein. | 03-08-2012 |
Patent application number | Description | Published |
20120046163 | COMPOSITION INCLUDING A LANTHANUM PEROVSKITE ON AN ALUMINA OR ALUMINIUM OXYHYDROXIDE SUBSTRATE, PREPARATION METHOD AND USE IN CATALYSIS - A composition is described that includes a perovskite of the formula LaMO | 02-23-2012 |
20120192823 | SYNERGISTIC DETERGENT AND ACTIVE METAL COMPOUND COMBINATION - Compositions that include a detergent composition and an active metal compound are described wherein the detergent composition includes a quaternary ammonium salt detergent and optionally an oxygen-containing detergent, and wherein the active metal compound is in the form of a colloidal dispersion, comprising an organic phase, particles of an iron compound in its amorphous form, and at least one amphiphilic agent. These compositions can be used in fuels to provide improved engine performance by, for example, reducing fuel injector fouling in the engine and/or by improving the regeneration of the engine's particulate exhaust trap. | 08-02-2012 |
20130306028 | DEVICE FOR DISPENSING AN ADDITIVE - The invention relates to a device for dispensing a liquid additive into a fuel circulation circuit for an internal combustion engine, comprising a reservoir ( | 11-21-2013 |
20140007494 | FUEL ADDITIVE COMPOSITION CONTAINING A DISPERSION OF IRON PARTICLES AND A DETERGENT - A composition contains an additive for assisting with regeneration of the PF in the form of an organic dispersion of iron particles in crystallized form and a detergent including a quaternary ammonium salt. | 01-09-2014 |
20140007495 | USE OF DISPERSIONS OF IRON PARTICLES AS FUEL ADDITIVE - The present invention relates to the use of dispersions including an organic phase, at least one amphiphilic agent and solid objects based on particles of an iron compound in the crystallized form with a small size, as a fuel additive. | 01-09-2014 |
20140013659 | ORGANIC DISPERSION OF IRON-BASED PARTICLES IN CRYSTALLIZED FORM - A dispersion includes an apolar organic phase, at least one amphiphilic agent, and solid objects based on particles of an iron compound in crystallized form of small size. | 01-16-2014 |
20140033604 | FUEL ADDITIVE CONTAINING A DISPERSION OF IRON PARTICLES AND AN AMMONIUM POLYESTER DETERGENT - A composition contains an additive for assisting with the regeneration of the PF in the form of an organic dispersion of iron particles and a detergent including a polyester quaternary ammonium salt. | 02-06-2014 |
20140048029 | PROCESS FOR OPERATING AN ENGINE SUPPLIED WITH A FUEL CONTAINING A CATALYST FOR REGENERATING A PARTICULATE FILTER - The invention relates to a process for operating an internal combustion engine of a vehicle equipped with an exhaust system comprising a catalysed particulate filter in which the engine is supplied with a fuel containing a catalyst for regenerating the particulate filter. The process is characterized in that the concentration of catalyst in the fuel varies discontinuously. | 02-20-2014 |
20140366615 | METHOD FOR DIAGNOSING THE MALFUNCTIONING OF A DEVICE FOR ADDING AN ADDITIVE INTO A FUEL FOR A VEHICLE, AND SYSTEM FOR IMPLEMENTING SAID METHOD - The invention relates to a method for diagnosing the malfunctioning of a device for adding an additive into a fuel for a vehicle comprising an internal combustion engine, said method including: a step of analyzing the fuel in order to determine a variation in the amount of additive in the fuel; a step of comparing the variation in the amount of additive, measured during the previous step, with a theoretical variation in said amount; a step of sending information when the difference between the measured variation and the theoretical variation exceeds a set value. The invention also relates to a system for adding an additive into fuel and for diagnosis for a vehicle comprising an internal combustion engine, which is intended for implementing said method. | 12-18-2014 |
20150148219 | COMPOSITION INCLUDING A LANTHANUM PEROVSKITE ON AN ALUMINA OR ALUMINIUM OXYHYDROXIDE SUBSTRATE, PREPARATION METHOD AND USE IN CATALYSIS - The composition according to the invention includes a perovskite of the formula LaMO | 05-28-2015 |
20150232775 | SYNERGISTIC DETERGENT AND ACTIVE METAL COMPOUND COMBINATION - The present invention relates to compositions containing a detergent composition and an active metal containing compound, where the detergent composition includes a quaternary ammonium salt detergent and optionally an oxygen-containing detergent, and where the active metal containing compound is in the form of a colloidal dispersion, comprising an organic phase, particles of an iron compound in its amorphous form, and at least one amphiphilic agent. These compositions may be used in fuels and provide improved engine performance when such fuels are used, specifically by reducing fuel injector fouling in the engine and/or by improving the regenera | 08-20-2015 |